Axo Longevity raises $5m seed to expand preventive health testing
The membership combines recurring lab tests, biomarker tracking and an AI health coach, with funding to grow its lab network and reach more European markets.
A recurring view of health markers
Axo members complete blood and urine tests through partner laboratories. The service turns more than 100 biomarkers into an explained dashboard, tracks results over time and provides an action plan with ongoing AI-supported guidance. Six-month testing cycles are designed to show how markers change rather than leave members with a one-off result.
The $5 million seed round will support a broader laboratory network, wearable integrations and an AI health copilot, while helping Axo enter additional European markets. The expansion builds the infrastructure around a membership model that depends on repeated testing and follow-through.
Use of funds
Expand its laboratory network, AI health copilot and wearable integrations; enter additional European markets